Topics

Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA

19:03 EDT 13 Sep 2019 | Xconomy

A panel of independent advisors to the FDA voted on Friday to recommend approval of an experimental peanut allergy drug from Aimmune Therapeutics. But concern about the risks of an allergic reaction to the therapy led the committee of mostly physicians to also recommend a safety plan to ensure that clinicians, patients, and their families […]

Original Article: Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA

NEXT ARTICLE

More From BioPortfolio on "Advisory Body Backs Aimmune Peanut Allergy Drug, Next Up: the FDA"

Quick Search

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...